Stull, Stull & Brody Announces Class Action Suit on Behalf of Shareholders of INC Research Holdings Inc. (NASDAQ: INCR)

NEW YORK, July 13, 2017 -- Stull, Stull & Brody ("SS&B") announces that a class action lawsuit was commenced in the United States District Court for the District of Delaware on behalf of shareholders of INC Research Holdings Inc. (“INC” or the “Company”) (NASDAQ:INCR), alleging violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the proposed merger between INC and inVentiv Health, Inc. (“inVentiv”).

The complaint alleges that in order to convince INC shareholders to vote in favor of the proposed merger, INC’s Board of Directors authorized the filing of a materially incomplete and misleading Definitive Proxy Statement with the Securities and Exchange Commission, in violation of the Securities Exchange Act of 1934.

If you have any questions concerning this notice or your rights or interests with respect to these matters, please contact Jason D’Agnenica, Esq. at Stull, Stull & Brody, by email to [email protected], by telephone at 1-800-337-4983 x145, or by fax to 212-490-2022.

SS&B has litigated class actions for violations of securities laws and breaches of fiduciary duty on behalf of defrauded investors over the past 40 years and has obtained court approval of substantial settlements on numerous occasions.  SS&B has offices in New York and Beverly Hills.  SS&B’s website (www.ssbny.com) has additional information about the firm.

Attorney advertising.  Prior results do not guarantee a similar outcome.  This press release may be considered Attorney Advertising in some jurisdictions under applicable laws and ethical rules.